These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1273 related items for PubMed ID: 7872665

  • 1. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
    Buø L, Bjørnland K, Karlsrud TS, Kvale D, Kjønniksen I, Fodstad O, Brandtzaeg P, Johansen HT, Aasen AO.
    Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
    Schaefer BM, Stark HJ, Fusenig NE, Todd RF, Kramer MD.
    Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
    [Abstract] [Full Text] [Related]

  • 3. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q, Liu K, Liu YX, Byrne S, Ockleford CD.
    Placenta; 2001 Apr; 22(2-3):186-99. PubMed ID: 11170823
    [Abstract] [Full Text] [Related]

  • 5. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
    Ohba K, Miyata Y, Kanda S, Koga S, Hayashi T, Kanetake H.
    J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA, Leaper DJ, Hayter JP, Dickenson AJ.
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [Abstract] [Full Text] [Related]

  • 7. Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression.
    Robert C, Bolon I, Gazzeri S, Veyrenc S, Brambilla C, Brambilla E.
    Clin Cancer Res; 1999 Aug; 5(8):2094-102. PubMed ID: 10473092
    [Abstract] [Full Text] [Related]

  • 8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R, Schaaf A.
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [Abstract] [Full Text] [Related]

  • 9. [Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
    Zhao EM, Han DM, Yu ZK, Fan EZ, Li Y.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):39-42. PubMed ID: 12778766
    [Abstract] [Full Text] [Related]

  • 10. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
    Hagiwara H, Sato H, Shirai S, Kobayashi S, Fukumoto K, Ishida T, Seki T, Ariga T, Yano T.
    Life Sci; 2006 Apr 04; 78(19):2249-54. PubMed ID: 16289236
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
    Kumamoto H, Ooya K.
    J Oral Pathol Med; 2007 Sep 04; 36(8):488-94. PubMed ID: 17686008
    [Abstract] [Full Text] [Related]

  • 12. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
    Foca C, Moses EK, Quinn MA, Rice GE.
    Gynecol Oncol; 2000 Nov 04; 79(2):244-50. PubMed ID: 11063652
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N, Maguire TM, Riisbro R, Geurts-Moespot A, O'Donovan N, Schmitt M, McGreal G, McDermott E, O'Higgins N, Brünner N, Sweep CG, Duffy MJ.
    Oncol Rep; 2005 Jul 04; 14(1):235-9. PubMed ID: 15944795
    [Abstract] [Full Text] [Related]

  • 15. Spitz naevi may express components of the plasminogen activation system.
    Ferrier CM, Van Geloof WL, Straatman H, Van De Molengraft FJ, Van Muijen GN, Ruiter DJ.
    J Pathol; 2002 Sep 04; 198(1):92-9. PubMed ID: 12210068
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Distinct patterns of urokinase receptor (uPAR) expression by leukemic cells and peripheral blood cells.
    Jardí M, Inglés-Esteve J, Burgal M, Azqueta C, Velasco F, López-Pedrera C, Miles LA, Félez J.
    Thromb Haemost; 1996 Dec 04; 76(6):1009-19. PubMed ID: 8972026
    [Abstract] [Full Text] [Related]

  • 18. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
    Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.
    J Lab Clin Med; 2004 Aug 04; 144(2):69-77. PubMed ID: 15322501
    [Abstract] [Full Text] [Related]

  • 19. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J, Pilka R, Noskova V, Ehinger A, Domanski H, Andersson C, Høyer-Hansen G, Hansson SR, Casslén B.
    Mol Hum Reprod; 2004 Sep 04; 10(9):655-63. PubMed ID: 15243126
    [Abstract] [Full Text] [Related]

  • 20. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M, Vaheri A, Virolainen S, Saarialho-Kere U, Jahkola T, Sirén V.
    Br J Dermatol; 2004 Dec 04; 151(6):1189-96. PubMed ID: 15606514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.